Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02329366 · ClinicalTrials.gov registry record
Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers
A clinical trial, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT02329366 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 30 participants.
The verdict
NCT02329366 has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This project aims to result in the identification of such markers, and the development of a feasible quantitative method of distinguishing between tissue that has the capacity to heal and tissue that does not, thus identifying a non-healing phenotype.
Interventions
- OTHER Specimen Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02329366
The ClinicalTrials.gov registry entry for NCT02329366 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Specimen Collection is the first listed.
NCT02329366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02329366 about?
NCT02329366 is a clinical study titled "Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers". This project aims to result in the identification of such markers, and the development of a feasible quantitative method of distinguishing between tissue that has the capacity to heal and tissue that does not, thus identifying a non-healing phenotype.
What is the current status of trial NCT02329366?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-12. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT02329366?
The interventions under investigation include: Specimen Collection (OTHER).
Who is sponsoring clinical trial NCT02329366?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.